Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride liposome, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing.
PURPOSE: This phase II trial is studying how well doxorubicin hydrochloride liposome works as
first-line therapy in treating older women with metastatic breast cancer.